Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Physiological Effects of Nebulized Salbutamol in Patients With Acute Respiratory Failure During HFNC

NCT06815679 is registered in ClinicalTrials.gov with Università degli Studi di Ferrara as lead sponsor.

NCT NCT06815679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06815679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Physiological Effects of Nebulized Salbutamol in Patients With Acute Respiratory Failure During HFNC
Lead sponsor
Università degli Studi di Ferrara
Phase
Phase 2/3
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
July 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, pneumonia